Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

Authors: Mösges, R., Koch, A. F., Raskopf, E., Singh, J., Shah‐Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R., Shamji, M. H.

Source: Allergy. 73(6):1254-1262

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100094113233.0x000001&indx=1&recIds=ETOCvdc_100094113233.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial.

Authors: Mösges, R., Bachert, C., Panzner, P., Calderon, M. A., Haazen, L., Pirotton, S., Wathelet, N., Durham, S. R., Bonny, M.‐A., Legon, T., von Frenckell, R., Pfaar, O., Shamji, M. H.

Source: Allergy; Sep2018, Vol. 73 Issue 9, p1842-1850, 9p, 1 Diagram, 3 Charts, 2 Graphs

Subject Terms: ALLERGIC conjunctivitis, ALTERNATIVE treatment for hay fever, ASTHMA treatment, LOLIUM perenne, PROVOCATION tests (Medicine), GRASS pollen, ALLERGY treatment, ALLERGIC rhinoconjunctivitis

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy.

Authors: Mösges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G., Shamji, M. H.

Source: Allergy; Apr2018, Vol. 73 Issue 4, p896-904, 9p, 1 Diagram, 2 Charts, 3 Graphs

Subject Terms: LOLIUM perenne, IMMUNOTHERAPY, CLINICAL immunology, ALLERGY treatment, IMMUNIZATION

Immunogenicity Evaluation of Subcutaneous Administration of Peptide Hydrolysate from Lolium Perenne (gpASIT+â„¢) in Combination with Bacterial HSP70 (DnaK) in Patients with Seasonal Allergic Rhinitis: A Double Blind Placebo Controlled Trial

Authors: Shamji, M. H., Ceuppens, J. L., Hellings, P. W., Durham, S., Duchateau, J., Parkin, R., Legon, T., Pirotton, S.

Source: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 135(2):AB159-AB159

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN366600034&indx=1&recIds=ETOCRN366600034

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.